BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27101240)

  • 1. Controversies in Screening Mammography.
    Swain M; Jeudy M; Pearlman MD
    Clin Obstet Gynecol; 2016 Jun; 59(2):351-61. PubMed ID: 27101240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.
    Duffy SW; Agbaje O; Tabar L; Vitak B; Bjurstam N; Björneld L; Myles JP; Warwick J
    Breast Cancer Res; 2005; 7(6):258-65. PubMed ID: 16457701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits and harms of breast cancer screening with mammography in women aged 40-49 years: A systematic review.
    van den Ende C; Oordt-Speets AM; Vroling H; van Agt HME
    Int J Cancer; 2017 Oct; 141(7):1295-1306. PubMed ID: 28542784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis.
    van Ravesteyn NT; Stout NK; Schechter CB; Heijnsdijk EA; Alagoz O; Trentham-Dietz A; Mandelblatt JS; de Koning HJ
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25948872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overdiagnosis in breast imaging.
    Evans A; Vinnicombe S
    Breast; 2017 Feb; 31():270-273. PubMed ID: 28029492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
    Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
    Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic assessment of benefits and risks to guide breast cancer screening decisions.
    Pace LE; Keating NL
    JAMA; 2014 Apr; 311(13):1327-35. PubMed ID: 24691608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects of screening mammography.
    Feig SA
    Radiol Clin North Am; 2004 Sep; 42(5):807-19, v. PubMed ID: 15337417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
    Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
    Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation.
    Nelson HD; Pappas M; Cantor A; Griffin J; Daeges M; Humphrey L
    Ann Intern Med; 2016 Feb; 164(4):256-67. PubMed ID: 26756737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality-of-life effects of screening mammography in Norway.
    Zahl PH; Kalager M; Suhrke P; Nord E
    Int J Cancer; 2020 Apr; 146(8):2104-2112. PubMed ID: 31254388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [To the Editors: Comment on the study by Kullmann and Misset "Benefits of mammographic breast cancer screening"].
    Kovács A; Budai A; Döbrössy L; Péntek Z; Ormándi K; Forrai G
    Orv Hetil; 2010 Dec; 151(49):2031-2, discussion 2033-4.. PubMed ID: 21106484
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening mammography starting at age 40: Still relevant.
    Ghosh K; Wahner-Roedler D; Brandt K
    Cleve Clin J Med; 2015 May; 82(5):276-9. PubMed ID: 25973872
    [No Abstract]   [Full Text] [Related]  

  • 14. Insights Into Breast Cancer Screening: A Computer Simulation of Two Contemporary Screening Strategies.
    Carter KJ; Castro F; Morcos RN
    AJR Am J Roentgenol; 2018 Mar; 210(3):564-571. PubMed ID: 29323554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
    Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
    Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening mammography following autologous breast reconstruction: an unnecessary effort.
    Freyvogel M; Padia S; Larson K; Dietz J; Grobmyer S; O'Rourke C; Valente S
    Ann Surg Oncol; 2014 Oct; 21(10):3256-60. PubMed ID: 25059787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avoiding Overtreatment of Ductal Carcinoma in situ.
    van der Borden CL; Stoffers S; Lips EH; Wesseling J
    Trends Cancer; 2019 Jul; 5(7):391-393. PubMed ID: 31311652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biennial versus annual mammography and the risk of late-stage breast cancer.
    White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
    J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing invasive breast cancer: another benefit from mammographic screening.
    Cady B; Chung MA
    Cancer; 2011 Jul; 117(14):3064-8. PubMed ID: 21246518
    [No Abstract]   [Full Text] [Related]  

  • 20. Overdiagnosis and Risks of Breast Cancer Screening.
    Neal CH; Helvie MA
    Radiol Clin North Am; 2021 Jan; 59(1):19-27. PubMed ID: 33222997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.